Cibus, Inc. (CBUS)
1.36
-0.02
(-1.45%)
USD |
NASDAQ |
May 22, 16:00
1.36
0.00 (0.00%)
After-Hours: 20:00
Cibus EPS Diluted (Quarterly) : -0.3255 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Protalix Biotherapeutics, Inc. | 0.2206 |
| CytomX Therapeutics, Inc. | -0.1029 |
| Pelthos Therapeutics, Inc. | -3.091 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.22M |
| Revenue (Quarterly) | 1.681M |
| Total Expenses (Quarterly) | 22.90M |
| Enterprise Value | 351.16M |
| Gross Profit Margin (Quarterly) | 28.79% |
| Profit Margin (Quarterly) | -1.26K% |
| Earnings Yield | -144.7% |
| Normalized Earnings Yield | -135.94 |